Patent 7235583 was granted and assigned to Luitpold Pharmaceuticals on June, 2007 by the United States Patent and Trademark Office.
The invention provides conjugates of fatty acids and anticancer agents useful in treating cancer, and compositions and formulations thereof. Methods for using the conjugates also are provided.